MannKind Stock (NASDAQ: MNKD) stock price, news, charts, stock research, profile.
Open | $4.450 |
Close | $4.390 |
Volume / Avg. | 1.836M / 2.898M |
Day Range | 4.340 - 4.490 |
52 Wk Range | 3.170 - 5.750 |
Market Cap | $1.170B |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 0 |
Short Interest | 11.5% |
Days to Cover | 10.88 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of MannKind (NASDAQ: MNKD) through any online brokerage.
Other companies in MannKind’s space includes: Macrogenics (NASDAQ:MGNX), Gyre Therapeutics (NASDAQ:GYRE), 4D Molecular Therapeutics (NASDAQ:FDMT), Centessa Pharmaceuticals (NASDAQ:CNTA) and Prothena Corp (NASDAQ:PRTA).
The latest price target for MannKind (NASDAQ: MNKD) was reported by Cantor Fitzgerald on Friday, March 15, 2024. The analyst firm set a price target for 6.50 expecting MNKD to rise to within 12 months (a possible 50.41% upside). 7 analyst firms have reported ratings in the last year.
The stock price for MannKind (NASDAQ: MNKD) is $4.3216 last updated May 3, 2024 at 5:48 PM EDT.
There are no upcoming dividends for MannKind.
MannKind’s Q1 earnings are confirmed for Wednesday, May 8, 2024.
There is no upcoming split for MannKind.
MannKind is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.